Alyeska Investment Group
KZR

Alyeska Investment Group’s Kezar Life Sciences KZR Stock Holding History

Alyeska Investment Group’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-38,383
Closed -$2.08M – 736
2021
Q2 		$2.08M Hold
38,383
– – 0.02% 505
2021
Q1 		$2.29M Sell
38,383
-20,000
-34% -$1.17M 0.03% 450
2020
Q4 		$3.05M Sell
58,383
-467
-0.8% -$26K 0.04% 336
2020
Q3 		$2.85M Hold
58,850
– – 0.04% 312
2020
Q2 		$3.05M Buy
58,850
+34,338
+140% +$1.73M 0.05% 322
2020
Q1 		$1.07M Buy
+24,512
New +$997K 0.02% 288
2019
Q4 		– Sell
-4,895
Closed -$161K – 460
2019
Q3 		$161K Hold
4,895
– – ﹤0.01% 388
2019
Q2 		$377K Buy
+4,895
New +$761K ﹤0.01% 412
2018
Q3 		– Sell
-7,500
Closed -$1.3M – 462
2018
Q2 		$1.3M Buy
+7,500
New +$1.31M 0.01% 380

Other funds holding KZR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Alyeska Investment Group's KZR Position: Q3 2021 in Review

Alyeska Investment Group sold out of Kezar Life Sciences (KZR) in Q3 2021, closing a stake of 38,383 shares — an estimated $2.08M sold.

Alyeska Investment Group first reported a position in KZR in Q2 2018 and held it in 9 quarters. The position peaked at $3.05M in Q4 2020. 76 funds tracked by Wall St. Rank hold KZR as of Q3 2021.

  • Alyeska Investment Group reported no remaining Kezar Life Sciences position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 38,383 Kezar Life Sciences shares in Q3 2021, an estimated $2.08M.
  • Alyeska Investment Group first reported a position in Kezar Life Sciences in Q2 2018 and held it in 9 quarters.
  • Alyeska Investment Group's Kezar Life Sciences position peaked at $3.05M in Q4 2020.
  • 76 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.